首页 > 最新文献

Annals of Saudi Medicine最新文献

英文 中文
Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals 对直接作用抗病毒药物有反应的慢性丙型肝炎患者的肝纤维化变化
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.89
K. Alswat, Fahad Al-Sohaibani, A. Khathlan, Ahmad Bashmail, M. Alanazi, A. Kurdi, Abdul Hakim Almakadma, W. Al-Hamoudi
BACKGROUND: Clearance of hepatitis C virus (HCV) can potentially slow or reverse liver fibrosis and cirrhosis. Studies of fibrosis changes after treatment with direct-acting antivirals (DAAs) are limited. OBJECTIVES: We aimed to assess the impact of DAAs on fibrosis in HCV treatment responders. DESIGN: Retrospective cohort study. SETTING: Tertiary care centers. PATIENTS AND METHODS: This study included adult patients who received DAA treatment for HCV (naïve and experienced) from June 2015 to January 2019 who were treatment responders. Biochemical and hematological data and noninvasive fibrosis markers were recorded at baseline and follow-up. MAIN OUTCOME MEASURES: Aspartate aminotransferase/platelet ratio index (APRI), fibrosis-4 score (FIB-4) and liver stiffness measurements (LSM) at baseline and follow-up. SAMPLE SIZE AND CHARACTERISTICS: 172 HCV treatment responders, mean (SD) age 54.1 (14.1) and body mass index 28.8 (6.5) kg/m2 at baseline; 96 (55.8%) were females. RESULTS: Fifty-eight (33.7%) patients were HCV treatment-experienced. Most patients were genotype 4 (n=125, 73%) and the mean follow-up was 141 (57.9) weeks. Compared with baseline, changes in alanine aminotransferase (P<.001), aspartate aminotransferase (P<.001), and albumin (P=.01) were statistically significant. Changes in LSM (15.09 kPa [11.4] vs. 10.19 kPa [7.4], P<.001), APRI (0.81 [0.7] vs. 0.34 [0.2], P<.001), and FIB-4 (1.99 [1.4) vs.1.35 [0.9], P<.001), and AST/ALT ratio (0.86 [0.32] vs. 0.95 [0.41], P=.015) were statistically significant. Differences in many of the same parameters were statistically significant between patients with low fibrosis (F0-F1) (n=59, 34.3%) and significant fibrosis (≥F2) (n=113, 65.7%). CONCLUSIONS: Our findings confirm that clearance of HCV with DAAs is associated with significant improvement in fibrosis as assessed by noninvasive liver fibrosis measures, which supports the concept of post-treatment fibrosis regression. Long follow-up studies are needed to assess the impact on morbidity and mortality. LIMITATIONS: Absence of histological correlation with these noninvasive scores. No assessment of fibrosis changes based on HCV geno-type or treatment regimen. CONFLICT OF INTEREST: None.
背景:清除丙型肝炎病毒(HCV)可能减缓或逆转肝纤维化和肝硬化。对直接作用抗病毒药物(DAAs)治疗后纤维化变化的研究有限。目的:我们旨在评估DAAs对HCV治疗应答者纤维化的影响。设计:回顾性队列研究。单位:三级护理中心。患者和方法:本研究包括2015年6月至2019年1月接受丙型肝炎DAA治疗的成年患者(幼稚且有经验),他们是治疗应答者。在基线和随访时记录生化和血液学数据以及无创纤维化标志物。主要观察指标:基线和随访时的天冬氨酸转氨酶/血小板比值指数(APRI)、纤维化-4评分(FIB-4)和肝硬度测量(LSM)。样本量和特征:172名HCV治疗应答者,基线时平均(SD)年龄54.1(14.1),体重指数28.8(6.5)kg/m2;女性96例(55.8%)。结果:58例(33.7%)患者有HCV治疗经验。大多数患者为基因型4(n=125,73%),平均随访141(57.9)周。与基线相比,丙氨酸转氨酶(P<.001)、天冬氨酸转氨酶(P<.001)和白蛋白(P=.01)的变化具有统计学意义。LSM(15.09 kPa[11.4]vs.10.19 kPa[7.4],P<.001)、APRI(0.81[0.7]vs.0.34[0.2],P<0.001)、FIB-4(1.99[1.4)vs.1.35[0.9],P<.001)和AST/ALT比率(0.86[0.32]vs.0.95[0.41],P=.015)的变化具有统计学意义。在低纤维化(F0-F1)(n=59,34.3%)和显著纤维化(≥F2)(n=113,65.7%)患者之间,许多相同参数的差异具有统计学意义,这支持了治疗后纤维化消退的概念。需要进行长期随访研究,以评估对发病率和死亡率的影响。局限性:与这些非侵入性评分缺乏组织学相关性。没有根据HCV基因型或治疗方案评估纤维化变化。利益冲突:无。
{"title":"Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals","authors":"K. Alswat, Fahad Al-Sohaibani, A. Khathlan, Ahmad Bashmail, M. Alanazi, A. Kurdi, Abdul Hakim Almakadma, W. Al-Hamoudi","doi":"10.5144/0256-4947.2022.89","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.89","url":null,"abstract":"BACKGROUND: Clearance of hepatitis C virus (HCV) can potentially slow or reverse liver fibrosis and cirrhosis. Studies of fibrosis changes after treatment with direct-acting antivirals (DAAs) are limited. OBJECTIVES: We aimed to assess the impact of DAAs on fibrosis in HCV treatment responders. DESIGN: Retrospective cohort study. SETTING: Tertiary care centers. PATIENTS AND METHODS: This study included adult patients who received DAA treatment for HCV (naïve and experienced) from June 2015 to January 2019 who were treatment responders. Biochemical and hematological data and noninvasive fibrosis markers were recorded at baseline and follow-up. MAIN OUTCOME MEASURES: Aspartate aminotransferase/platelet ratio index (APRI), fibrosis-4 score (FIB-4) and liver stiffness measurements (LSM) at baseline and follow-up. SAMPLE SIZE AND CHARACTERISTICS: 172 HCV treatment responders, mean (SD) age 54.1 (14.1) and body mass index 28.8 (6.5) kg/m2 at baseline; 96 (55.8%) were females. RESULTS: Fifty-eight (33.7%) patients were HCV treatment-experienced. Most patients were genotype 4 (n=125, 73%) and the mean follow-up was 141 (57.9) weeks. Compared with baseline, changes in alanine aminotransferase (P<.001), aspartate aminotransferase (P<.001), and albumin (P=.01) were statistically significant. Changes in LSM (15.09 kPa [11.4] vs. 10.19 kPa [7.4], P<.001), APRI (0.81 [0.7] vs. 0.34 [0.2], P<.001), and FIB-4 (1.99 [1.4) vs.1.35 [0.9], P<.001), and AST/ALT ratio (0.86 [0.32] vs. 0.95 [0.41], P=.015) were statistically significant. Differences in many of the same parameters were statistically significant between patients with low fibrosis (F0-F1) (n=59, 34.3%) and significant fibrosis (≥F2) (n=113, 65.7%). CONCLUSIONS: Our findings confirm that clearance of HCV with DAAs is associated with significant improvement in fibrosis as assessed by noninvasive liver fibrosis measures, which supports the concept of post-treatment fibrosis regression. Long follow-up studies are needed to assess the impact on morbidity and mortality. LIMITATIONS: Absence of histological correlation with these noninvasive scores. No assessment of fibrosis changes based on HCV geno-type or treatment regimen. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"89 - 95"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42519735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comment on: Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women 评论:科威特国家乳房x光检查项目:科威特妇女5年筛查的结果
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.145
F. Kashoo, Mehrunnisha Ahmad, M. Sidiq, H. Alkhawari
We read the research published in your journal titled “Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women” on 7 October 2021.1 We would like to commend the authors on such an elaborate and plausible article. The article provides a great deal of information on the prevalence of breast cancer among women in Kuwait despite poor participation. The study was a population-based screening study carried out from 2014-2019 among 14 773 asymptomatic women for possible breast cancer. The study identified 551 women with lesions by a full-field digital mammography system. The article indeed adds value to the early detection of breast cancer in women in Kuwait. However, collecting more information about risk factors from women (n=551) diagnosed with breast lesions would further improve the understanding of contributing risk factors and designing targeted breast cancer screening programs. Although, the authors mentioned that the screening was done for a specific age group (40-69 years old). The known risk factors that can uniquely contribute to the occurrence of breast cancer are obesity,2 age of menarche,3 late age of menopause,3 pre-existing metabolic disorders,4 smoking habit,5 dietary habits,6 blood group,7 level of physical activity,6 consumption of caffeine, vitamin D deficiency, duration of sleep, air population,8 night work, diabetes,7 and radiation exposure.7 Information collected based on the above mentioned risk factors would greatly add to the understanding of the unique contribution of these risk factors to the occurrence of breast cancer. Moreover, the statement in the result section of the abstract of the manuscript states that the percentage of women with breast cancer between the 40-49 year age group was 23.1%.
我们阅读了你们杂志于2021年10月7日发表的题为“科威特国家乳房x线摄影筛查计划:科威特妇女5年筛查的结果”的研究。我们想要赞扬作者的这篇精心制作和可信的文章。这篇文章提供了大量关于科威特妇女乳腺癌患病率的信息,尽管她们的参与率很低。该研究是一项基于人群的筛查研究,从2014年到2019年,在14773名可能患有乳腺癌的无症状女性中进行。该研究通过全视野数字乳房x线摄影系统确定了551名患有病变的女性。这篇文章确实为科威特妇女乳腺癌的早期发现增加了价值。然而,从被诊断为乳房病变的妇女(n=551)收集更多有关危险因素的信息,将进一步提高对危险因素的理解,并设计有针对性的乳腺癌筛查项目。虽然,作者提到筛查是针对特定年龄组(40-69岁)进行的。已知的唯一可能导致乳腺癌发生的危险因素是肥胖,2月经初潮年龄,3绝经年龄较晚,3先前存在的代谢紊乱,4吸烟习惯,5饮食习惯,6血型,7身体活动水平,6咖啡因摄入,维生素D缺乏,睡眠时间,空气人口,8夜班,糖尿病,7和辐射暴露根据上述风险因素收集的信息将大大有助于了解这些风险因素对乳腺癌发生的独特作用。此外,手稿摘要结果部分的陈述指出,40-49岁年龄组的女性患乳腺癌的比例为23.1%。
{"title":"Comment on: Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women","authors":"F. Kashoo, Mehrunnisha Ahmad, M. Sidiq, H. Alkhawari","doi":"10.5144/0256-4947.2022.145","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.145","url":null,"abstract":"We read the research published in your journal titled “Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women” on 7 October 2021.1 We would like to commend the authors on such an elaborate and plausible article. The article provides a great deal of information on the prevalence of breast cancer among women in Kuwait despite poor participation. The study was a population-based screening study carried out from 2014-2019 among 14 773 asymptomatic women for possible breast cancer. The study identified 551 women with lesions by a full-field digital mammography system. The article indeed adds value to the early detection of breast cancer in women in Kuwait. However, collecting more information about risk factors from women (n=551) diagnosed with breast lesions would further improve the understanding of contributing risk factors and designing targeted breast cancer screening programs. Although, the authors mentioned that the screening was done for a specific age group (40-69 years old). The known risk factors that can uniquely contribute to the occurrence of breast cancer are obesity,2 age of menarche,3 late age of menopause,3 pre-existing metabolic disorders,4 smoking habit,5 dietary habits,6 blood group,7 level of physical activity,6 consumption of caffeine, vitamin D deficiency, duration of sleep, air population,8 night work, diabetes,7 and radiation exposure.7 Information collected based on the above mentioned risk factors would greatly add to the understanding of the unique contribution of these risk factors to the occurrence of breast cancer. Moreover, the statement in the result section of the abstract of the manuscript states that the percentage of women with breast cancer between the 40-49 year age group was 23.1%.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"145 - 145"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42068143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study 冠状动脉内肾上腺素与腺苷治疗难治性无血流现象:一项单中心回顾性队列研究
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.75
Ahmed Darwish, A. Frere, M. Abdelsamie, Waleed El Awady, M. Gouda
BACKGROUND: The no-reflow phenomenon is associated with a considerable reduction in myocardial salvage in patients with ST elevation myocardial infarction (STEMI) treated by primary percutaneous intervention (PCI). There has been no head-to-head comparison of intra-coronary epinephrine to adenosine in the management of no-reflow phenomenon. OBJECTIVES: Evaluate the short- and long-term efficacy and safety of using intracoronary epinephrine versus adenosine for management of the catastrophic no-reflow phenomenon that may occur during primary PCI. DESIGN: Retrospective cohort. SETTING: Single center in Egypt. PATIENTS AND METHODS: The study included STEMI patients who developed refractory no-reflow phenomenon during primary PCI after failure of conventional treatments and received either intracoronary epinephrine or adenosine. MAIN OUTCOME MEASURES: No-reflow management measured through improvement of thrombolysis in myocardial infarction grade (TIMI flow), myocardial blush grade, TIMI frame count and major adverse cardiovascular events (MACE) at 1-year follow up. SAMPLE SIZE: 156 patients with refractory no-reflow phenomenon during primary PCI. RESULTS: Successful reperfusion was achieved in 74 of 81 (91.4%) of patients who received epinephrine and in 65 of 75 (86.7%) who received adenosine (P<.05). Fifty-six of 81 patients (69.1%) achieved TIMI III flow after epinephrine administration versus 39 of 75 patients (52.7%) in the adenosine group (P=.04). The incidence of heart failure after 1 year of follow up was lower in the epinephrine group compared to the adenosine group (6.3% vs. 19.2%, P<.017). MACE after 1 year of follow up was lower in patients who received epinephrine compared to those who received adenosine (11.3 % Vs. 26.7 %, P<.01). CONCLUSION: During primary PCI, intracoronary epinephrine is as effective as adenosine in successful management of refractory no-reflow phenomenon with a more favorable long-term prognosis compared to adenosine. LIMITATIONS: Retrospective design. CONFLICT OF INTEREST: None.
背景:ST段抬高型心肌梗死(STEMI)患者经初级经皮介入治疗(PCI)后,无再流现象与心肌挽回率显著降低相关。目前还没有冠状动脉内肾上腺素与腺苷在无血流现象治疗中的直接比较。目的:评估冠状动脉内肾上腺素与腺苷治疗首次PCI期间可能发生的灾难性无血流现象的短期和长期疗效和安全性。设计:回顾性队列。环境:在埃及有一个中心。患者和方法:该研究纳入STEMI患者,这些患者在常规治疗失败后在首次PCI中出现难治性无回流现象,并接受冠状动脉内肾上腺素或腺苷治疗。主要观察指标:通过1年随访时心肌梗死等级(TIMI流量)、心肌红肿等级、TIMI框架计数和主要不良心血管事件(MACE)的溶栓改善来衡量无血流管理。样本量:156例在初次PCI治疗中出现难治性无回流现象的患者。结果:肾上腺素组81例患者中74例(91.4%)再灌注成功,腺苷组75例患者中65例(86.7%)再灌注成功(P< 0.05)。81例患者中56例(69.1%)在肾上腺素给药后达到TIMI III型血流,而腺苷组75例患者中39例(52.7%)(P= 0.04)。随访1年后,肾上腺素组心衰发生率低于腺苷组(6.3% vs. 19.2%, P< 0.017)。随访1年后,肾上腺素组的MACE低于腺苷组(11.3% Vs. 26.7%, P< 0.01)。结论:在初次PCI中,冠状动脉内肾上腺素与腺苷一样有效,可成功治疗难治性无血流再流现象,且长期预后优于腺苷。局限性:回顾性设计。利益冲突:无。
{"title":"Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study","authors":"Ahmed Darwish, A. Frere, M. Abdelsamie, Waleed El Awady, M. Gouda","doi":"10.5144/0256-4947.2022.75","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.75","url":null,"abstract":"BACKGROUND: The no-reflow phenomenon is associated with a considerable reduction in myocardial salvage in patients with ST elevation myocardial infarction (STEMI) treated by primary percutaneous intervention (PCI). There has been no head-to-head comparison of intra-coronary epinephrine to adenosine in the management of no-reflow phenomenon. OBJECTIVES: Evaluate the short- and long-term efficacy and safety of using intracoronary epinephrine versus adenosine for management of the catastrophic no-reflow phenomenon that may occur during primary PCI. DESIGN: Retrospective cohort. SETTING: Single center in Egypt. PATIENTS AND METHODS: The study included STEMI patients who developed refractory no-reflow phenomenon during primary PCI after failure of conventional treatments and received either intracoronary epinephrine or adenosine. MAIN OUTCOME MEASURES: No-reflow management measured through improvement of thrombolysis in myocardial infarction grade (TIMI flow), myocardial blush grade, TIMI frame count and major adverse cardiovascular events (MACE) at 1-year follow up. SAMPLE SIZE: 156 patients with refractory no-reflow phenomenon during primary PCI. RESULTS: Successful reperfusion was achieved in 74 of 81 (91.4%) of patients who received epinephrine and in 65 of 75 (86.7%) who received adenosine (P<.05). Fifty-six of 81 patients (69.1%) achieved TIMI III flow after epinephrine administration versus 39 of 75 patients (52.7%) in the adenosine group (P=.04). The incidence of heart failure after 1 year of follow up was lower in the epinephrine group compared to the adenosine group (6.3% vs. 19.2%, P<.017). MACE after 1 year of follow up was lower in patients who received epinephrine compared to those who received adenosine (11.3 % Vs. 26.7 %, P<.01). CONCLUSION: During primary PCI, intracoronary epinephrine is as effective as adenosine in successful management of refractory no-reflow phenomenon with a more favorable long-term prognosis compared to adenosine. LIMITATIONS: Retrospective design. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"75 - 82"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44750235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia 沙特阿拉伯单一中心患者中SARS-Cov-2 IgG抗体的血清阳性率
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.69
Waleed H. Mahallawi, Mohammad A Alsarani, Rami H Aljohani, Abdulrahman A Alluhaibi, Turki H Alamri, Nadir A. Ibrahim, Khalid H Mahallawi, Omar F. Khabourd
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has had a massive impact on public health as well as the economy. Understanding the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among undiagnosed individuals is important for developing an informed pandemic response. OBJECTIVE: Investigate the prevalence of undiagnosed COVID-19 disease. DESIGN: Cross-sectional. SETTING: Tertiary care center in Madinah, Saudi Arabia. SUBJECTS AND METHODS: All participants were on follow-up visits to various clinics and had not been previously diagnosed with COVID-19. Enzyme-linked immunosorbent assay was used to specifically assess the anti-spike IgG antibody seropositivity in serum samples. We associated the seropositivity rates of the participants with age, body mass index (BMI), nationality, blood groups, and sex with uni- and multivariate analyses. MAIN OUTCOME MEASURES: Seropositivity for IgG anti-spike antibodies against SARS-CoV-2. SAMPLE SIZE AND CHARACTERISTICS: 527 subjects, with a median (interquartile percentiles) age of the 527 subjects was 34 (24–41). RESULTS: Of the 527 samples, about one-fourth (n=124, 23.5%) were positive for anti-spike IgG antibody against SARS CoV-2. Age was associated with anti-spike IgG antibody positivity (P<.002). Participants >30 years were more likely to be seropositive (28-29%) than younger participants (15.4%). Additionally, seropositivity was associated with female gender (P<.001) and a higher BMI (P<.006). In the multivariate logistic regression, age >30, female gender and BMI >40 were associated with seropositivity. CONCLUSION: The percentage of seropositive individuals reflects the high level of undiagnosed COVID-19 patients among the population. Our results will help in a better evaluation of the public health measures applied during the COVID-19 pandemic and any future public health crises. LIMITATIONS: Sample size was small, single-center study and no rural areas were included. CONFLICT OF INTEREST: None.
背景:2019冠状病毒病(新冠肺炎)大流行对公共卫生和经济产生了巨大影响。了解未确诊个体中严重急性呼吸综合征冠状病毒2型(严重急性呼吸系统综合征冠状病毒冠状病毒2型)感染的血清流行率对于制定知情的大流行应对措施很重要。目的:调查未确诊新冠肺炎的患病率。设计:横截面。单位:沙特阿拉伯麦地那的三级护理中心。受试者和方法:所有参与者都在各个诊所进行随访,之前未被诊断为新冠肺炎。酶联免疫吸附试验用于特异性评估血清样品中的抗刺突IgG抗体血清阳性。我们通过单因素和多因素分析将参与者的血清阳性率与年龄、体重指数(BMI)、国籍、血型和性别联系起来。主要观察指标:抗严重急性呼吸系统综合征冠状病毒2型IgG抗刺突抗体血清阳性。样本量和特征:527名受试者的中位(四分位数间)年龄为34岁(24-41岁)。结果:在527份样本中,约四分之一(n=124,23.5%)的SARS冠状病毒2型抗刺突IgG抗体呈阳性。年龄与抗刺突IgG抗体阳性相关(P30岁的参与者血清阳性率(28-29%)高于年轻参与者(15.4%)。此外,血清阳性与女性相关(P30,女性和BMI>40与血清阳性有关。结论:血清阳性个体的百分比反映了人群中未确诊新冠肺炎患者的高水平。我们的结果将有助于更好地评估新冠肺炎大流行和任何未来公共卫生危机期间采取的公共卫生措施。限制:样本量小,单一er研究,不包括农村地区。利益冲突:无。
{"title":"Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia","authors":"Waleed H. Mahallawi, Mohammad A Alsarani, Rami H Aljohani, Abdulrahman A Alluhaibi, Turki H Alamri, Nadir A. Ibrahim, Khalid H Mahallawi, Omar F. Khabourd","doi":"10.5144/0256-4947.2022.69","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.69","url":null,"abstract":"BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has had a massive impact on public health as well as the economy. Understanding the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among undiagnosed individuals is important for developing an informed pandemic response. OBJECTIVE: Investigate the prevalence of undiagnosed COVID-19 disease. DESIGN: Cross-sectional. SETTING: Tertiary care center in Madinah, Saudi Arabia. SUBJECTS AND METHODS: All participants were on follow-up visits to various clinics and had not been previously diagnosed with COVID-19. Enzyme-linked immunosorbent assay was used to specifically assess the anti-spike IgG antibody seropositivity in serum samples. We associated the seropositivity rates of the participants with age, body mass index (BMI), nationality, blood groups, and sex with uni- and multivariate analyses. MAIN OUTCOME MEASURES: Seropositivity for IgG anti-spike antibodies against SARS-CoV-2. SAMPLE SIZE AND CHARACTERISTICS: 527 subjects, with a median (interquartile percentiles) age of the 527 subjects was 34 (24–41). RESULTS: Of the 527 samples, about one-fourth (n=124, 23.5%) were positive for anti-spike IgG antibody against SARS CoV-2. Age was associated with anti-spike IgG antibody positivity (P<.002). Participants >30 years were more likely to be seropositive (28-29%) than younger participants (15.4%). Additionally, seropositivity was associated with female gender (P<.001) and a higher BMI (P<.006). In the multivariate logistic regression, age >30, female gender and BMI >40 were associated with seropositivity. CONCLUSION: The percentage of seropositive individuals reflects the high level of undiagnosed COVID-19 patients among the population. Our results will help in a better evaluation of the public health measures applied during the COVID-19 pandemic and any future public health crises. LIMITATIONS: Sample size was small, single-center study and no rural areas were included. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"69 - 74"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45462643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Renal lymphangiectasia in pediatric population: case series and review of literature 儿童肾淋巴管扩张症病例系列及文献复习
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.139
S. Alshanafey, Abdullah Alkhani, Abdulaziz Alkibsib
Renal lymphangiectasia is a rare disorder where perirenal, parapelvic, and/or intra-renal lymphatics are dilated. The clinical presentation of renal lymphangiectasia can range from asymptomatic to renal failure. Ultrasound, computed tomography and magnetic resonance imaging have been used for the diagnosis. Management of such cases varies from conservative to nephrectomy. We report three cases of pediatric renal lymphangiectasia that were managed by recurrent sclerothera-pies and medical supportive treatment at our institution. A literature review is also presented. To the best of our knowledge, there are 83 reported cases in the literature, 60 adults and 23 pediatrics.
肾淋巴管扩张是一种罕见的疾病,主要表现为肾周、肾盂旁和/或肾内淋巴管扩张。肾淋巴管扩张的临床表现可以从无症状到肾功能衰竭。超声,计算机断层扫描和磁共振成像已被用于诊断。这种病例的治疗方法从保守到肾切除不等。我们报告三例小儿肾淋巴管扩张,在我们的机构通过反复硬化疗法和医学支持治疗进行管理。文献综述也提出。据我们所知,文献中有83例报告病例,60例成人和23例儿科。
{"title":"Renal lymphangiectasia in pediatric population: case series and review of literature","authors":"S. Alshanafey, Abdullah Alkhani, Abdulaziz Alkibsib","doi":"10.5144/0256-4947.2022.139","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.139","url":null,"abstract":"Renal lymphangiectasia is a rare disorder where perirenal, parapelvic, and/or intra-renal lymphatics are dilated. The clinical presentation of renal lymphangiectasia can range from asymptomatic to renal failure. Ultrasound, computed tomography and magnetic resonance imaging have been used for the diagnosis. Management of such cases varies from conservative to nephrectomy. We report three cases of pediatric renal lymphangiectasia that were managed by recurrent sclerothera-pies and medical supportive treatment at our institution. A literature review is also presented. To the best of our knowledge, there are 83 reported cases in the literature, 60 adults and 23 pediatrics.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"139 - 144"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42320876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia 沙特阿拉伯新生儿先天性代谢异常筛查的截断值
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.107
Adbul Rafiq Khan, A. Alothaim, A. Alfares, Adil Jowed, Souad Marwan Al Enazi, S. A. Ghamdi, Ahmed Al Seneid, Areej Algahtani, Saleh Al Zahrani, M. Alfadhel, O. Aldibasi, Lamya A. Alomair, Rafah Bajudah, Abeer Nawaf Alanazie
BACKGROUND: Newborn screening identifies individuals affected by a specific disorder within an apparently healthy population prior to the appearance of symptoms so that appropriate interventions can be initiated in time to minimize the harmful effects. Data on population based cut-off values, disease ranges for true positive cases, false positive rates, true positive rates, cut-off verification and comparisons with international cut-off ranges have not been done for Saudi Arabia. OBJECTIVE: Establish population-based cut-off values and analyte ratios for newborn screening assays and clinically validate the values. DESIGN: Population-based screening. SETTING: Tertiary care hospitals and laboratories. METHODS: After method verification, initial cut-off values were established by analyzing 400-500 dry blood spot (DBS) samples which were further evaluated after one year. About 74 000 patient results were reviewed to establish cut-off ranges from DBS samples received from five different hospitals during 2013-2020. Analysis was performed by tandem mass spectrometry (TMS) and a genetic screening processor. Confirmation of initial positive newborn screening results for different analytes were carried out using gas chromatography-mass spectrometry, high performance liquid chromatography and TMS. MAIN OUTCOME MEASURES: Cut-off values, ratios, positive predictive values, false positive rate, true positive rate and disease range. SAMPLE SIZE: 74 000 samples. RESULTS: Population based cut-off values were calculated at different percentiles. These values were compared with 156 true positive samples and 80 proficiency samples. The false positive rate was less than 0.04 for all the analytes, except for valine, leucine, isovalerylcarnitine (C5), biotinidase (BTD), 17-hydroxyprogesterone and thyroid stimulating hormone. The highest false positive rate was 0.14 for BTD which was due to pre-analytical errors. The analytical positive predictive values were greater than 80% throughout the eight years. CONCLUSION: We have established clinical disease ranges for most of the analytes tested in our lab and several ratios which gives excellent screening specificity and sensitivity for early detection. The samples were representative of the local populations. LIMITATIONS: Need for wider, population-based studies. CONFLICT OF INTEREST: None.
背景:新生儿筛查在症状出现之前识别出明显健康人群中受特定疾病影响的个体,以便及时启动适当的干预措施,以尽量减少有害影响。沙特阿拉伯没有关于基于人口的临界值、真阳性病例的疾病范围、假阳性率、真阳性率、临界值核查以及与国际临界值范围比较的数据。目的:建立基于人群的新生儿筛查测定的临界值和分析物比率,并对其进行临床验证。设计:基于人群的筛查。单位:三级保健医院和实验室。方法:方法验证后,通过分析400-500份干血斑(DBS)样本建立初始临界值,1年后进一步评估。对2013-2020年期间从五家不同医院收到的DBS样本进行了审查,以确定其截止范围。采用串联质谱(TMS)和遗传筛选处理器进行分析。采用气相色谱-质谱法、高效液相色谱法和TMS对不同分析物的初步阳性新生儿筛查结果进行确认。主要观察指标:截断值、比率、阳性预测值、假阳性率、真阳性率、疾病范围。样本数量:74000个样本。结果:以不同百分位数计算基于人群的临界值。这些值与156个真阳性样本和80个熟练度样本进行了比较。除缬氨酸、亮氨酸、异戊基肉碱(C5)、生物素酶(BTD)、17-羟孕酮和促甲状腺激素外,其余检测结果的假阳性率均小于0.04。由于分析前错误,BTD的最高假阳性率为0.14。8年的分析阳性预测值大于80%。结论:本实验室所检测的大部分分析物均有确定的临床发病范围和若干比值,具有良好的筛查特异性和早期发现的敏感性。这些样本代表了当地人口。局限性:需要更广泛的、基于人群的研究。利益冲突:无。
{"title":"Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia","authors":"Adbul Rafiq Khan, A. Alothaim, A. Alfares, Adil Jowed, Souad Marwan Al Enazi, S. A. Ghamdi, Ahmed Al Seneid, Areej Algahtani, Saleh Al Zahrani, M. Alfadhel, O. Aldibasi, Lamya A. Alomair, Rafah Bajudah, Abeer Nawaf Alanazie","doi":"10.5144/0256-4947.2022.107","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.107","url":null,"abstract":"BACKGROUND: Newborn screening identifies individuals affected by a specific disorder within an apparently healthy population prior to the appearance of symptoms so that appropriate interventions can be initiated in time to minimize the harmful effects. Data on population based cut-off values, disease ranges for true positive cases, false positive rates, true positive rates, cut-off verification and comparisons with international cut-off ranges have not been done for Saudi Arabia. OBJECTIVE: Establish population-based cut-off values and analyte ratios for newborn screening assays and clinically validate the values. DESIGN: Population-based screening. SETTING: Tertiary care hospitals and laboratories. METHODS: After method verification, initial cut-off values were established by analyzing 400-500 dry blood spot (DBS) samples which were further evaluated after one year. About 74 000 patient results were reviewed to establish cut-off ranges from DBS samples received from five different hospitals during 2013-2020. Analysis was performed by tandem mass spectrometry (TMS) and a genetic screening processor. Confirmation of initial positive newborn screening results for different analytes were carried out using gas chromatography-mass spectrometry, high performance liquid chromatography and TMS. MAIN OUTCOME MEASURES: Cut-off values, ratios, positive predictive values, false positive rate, true positive rate and disease range. SAMPLE SIZE: 74 000 samples. RESULTS: Population based cut-off values were calculated at different percentiles. These values were compared with 156 true positive samples and 80 proficiency samples. The false positive rate was less than 0.04 for all the analytes, except for valine, leucine, isovalerylcarnitine (C5), biotinidase (BTD), 17-hydroxyprogesterone and thyroid stimulating hormone. The highest false positive rate was 0.14 for BTD which was due to pre-analytical errors. The analytical positive predictive values were greater than 80% throughout the eight years. CONCLUSION: We have established clinical disease ranges for most of the analytes tested in our lab and several ratios which gives excellent screening specificity and sensitivity for early detection. The samples were representative of the local populations. LIMITATIONS: Need for wider, population-based studies. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"107 - 118"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46191340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Diabetic ketoacidosis in Saudi Arabia: factors precipitating initial admission and readmission 沙特阿拉伯糖尿病酮症酸中毒:导致初次入院和再次入院的因素
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.119
Raghad Alotaibi, M. Alsulami, Sumiah Hijji, Saad Alghamdi, Yasser A Alnahdi, Haifa Alnahdi, S. Samargandy
BACKGROUND: Diabetic ketoacidosis (DKA) is one of the complications of diabetes mellitus (DM), primarily type 1 DM. To our knowledge, only one study explored DKA readmission rates in Saudi Arabia. OBJECTIVES: Identify and analyze precipitating factors for DKA admission and readmission. DESIGN: Medical record review. SETTING: Tertiary care center. PATIENTS AND METHODS: We identified all patients aged 15 years and older admitted with DKA from 2018 to 2020. Descriptive factors and uni-and multivariate analyses are presented for associations with initial admission and readmission. MAIN OUTCOME MEASURES: Relationships between precipitating factors and initial admission and readmission. SAMPLE SIZE: 176 patients. RESULTS: Most of the patients had type 1 DM (n=157). The median (interquartile percentiles) for duration of DM was 6.0 (1.0-12.0) years. The mean (SD) HbA1C (%) was 11.8 (2.6). The factors that precipitated DKA were most commonly treatment nonadherence (55.1%), followed by infections (31.8%) and nonadherence to diet (25.6%). The most common symptoms were nausea and vomiting (87.5%), followed by abdominal pain (72.7%). During the study period, 32.4% of the sample were read-mitted with DKA. The median (interquartile range) duration between the first and second admission was 12 (4-25) weeks. In the multivariate analysis, increased odds of readmission for DKA were associated with type 1 DM and medication nonadherence (P=.038, P=.013, respectively). The severity of the initial DKA and the control of DM were not associated with the readmission rate. CONCLUSION: Treatment nonadherence is the leading precipitating factor of DKA in our region. Patient education and counseling play a major role in addressing this preventable complication and its medical and financial burden. We advocate more efforts dedicated toward patient education and logistic support. LIMITATIONS: Retrospective-single center. CONFLICT OF INTEREST: None.
背景:糖尿病酮症酸中毒(DKA)是糖尿病(DM)的并发症之一,主要是1型糖尿病。据我们所知,只有一项研究探讨了沙特阿拉伯的DKA再入院率。目的:确定和分析DKA入院和再入院的促发因素。设计:病历回顾。环境:三级保健中心。患者和方法:我们确定了2018年至2020年期间所有年龄在15岁及以上的DKA患者。描述因素和单一和多变量分析提出了与初次入院和再入院的关系。主要观察指标:诱发因素与初次入院和再入院的关系。样本量:176例患者。结果:多数患者为1型糖尿病(157例)。糖尿病持续时间的中位数(四分位数)为6.0(1.0-12.0)年。平均(SD) HbA1C(%)为11.8(2.6%)。导致DKA的最常见因素是治疗不依从(55.1%),其次是感染(31.8%)和饮食不依从(25.6%)。最常见的症状是恶心和呕吐(87.5%),其次是腹痛(72.7%)。在研究期间,32.4%的样本被DKA读取。第一次和第二次入院的中位(四分位数范围)持续时间为12(4-25)周。在多变量分析中,DKA再入院的几率增加与1型糖尿病和药物依从性不相关(P=。038, P =。013年,分别)。初始DKA的严重程度和DM的控制与再入院率无关。结论:治疗不依从是本区DKA的主要诱发因素。患者教育和咨询在解决这一可预防的并发症及其医疗和经济负担方面发挥着重要作用。我们提倡在患者教育和后勤支持方面做出更多的努力。局限性:单中心回顾性研究。利益冲突:无。
{"title":"Diabetic ketoacidosis in Saudi Arabia: factors precipitating initial admission and readmission","authors":"Raghad Alotaibi, M. Alsulami, Sumiah Hijji, Saad Alghamdi, Yasser A Alnahdi, Haifa Alnahdi, S. Samargandy","doi":"10.5144/0256-4947.2022.119","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.119","url":null,"abstract":"BACKGROUND: Diabetic ketoacidosis (DKA) is one of the complications of diabetes mellitus (DM), primarily type 1 DM. To our knowledge, only one study explored DKA readmission rates in Saudi Arabia. OBJECTIVES: Identify and analyze precipitating factors for DKA admission and readmission. DESIGN: Medical record review. SETTING: Tertiary care center. PATIENTS AND METHODS: We identified all patients aged 15 years and older admitted with DKA from 2018 to 2020. Descriptive factors and uni-and multivariate analyses are presented for associations with initial admission and readmission. MAIN OUTCOME MEASURES: Relationships between precipitating factors and initial admission and readmission. SAMPLE SIZE: 176 patients. RESULTS: Most of the patients had type 1 DM (n=157). The median (interquartile percentiles) for duration of DM was 6.0 (1.0-12.0) years. The mean (SD) HbA1C (%) was 11.8 (2.6). The factors that precipitated DKA were most commonly treatment nonadherence (55.1%), followed by infections (31.8%) and nonadherence to diet (25.6%). The most common symptoms were nausea and vomiting (87.5%), followed by abdominal pain (72.7%). During the study period, 32.4% of the sample were read-mitted with DKA. The median (interquartile range) duration between the first and second admission was 12 (4-25) weeks. In the multivariate analysis, increased odds of readmission for DKA were associated with type 1 DM and medication nonadherence (P=.038, P=.013, respectively). The severity of the initial DKA and the control of DM were not associated with the readmission rate. CONCLUSION: Treatment nonadherence is the leading precipitating factor of DKA in our region. Patient education and counseling play a major role in addressing this preventable complication and its medical and financial burden. We advocate more efforts dedicated toward patient education and logistic support. LIMITATIONS: Retrospective-single center. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"119 - 126"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47615339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: a case-control study 沙特三级医疗中心维生素D受体基因变异与白癜风的相关性:一项病例对照研究
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.96
G. B. Saif, I. Khan
BACKGROUND: Vitiligo is a common cutaneous disorder of the skin and hair caused by a systemic depigmentation disorder that affects 1% of the population or less due to its onset in early adulthood. Meta-analyses have documented a linkage between vitiligo and the vitamin D receptor (VDR) gene. OBJECTIVE: Investigate the relationship between the ApaI, BsmI, FokI and TaqI genetic variants in the VDR gene with vitiligo in a Saudi population. DESIGN: Case-control. SETTING: Single tertiary care center. PATIENT AND METHODS: The case-control study was carried out between January 2015-December 2015 in Saudi vitiligo patients and healthy controls. VDR genetic variants or polymorphisms (ApaI, BsmI, FokI and TaqI) were genotyped by polymerase chain reaction-restriction fragment length analysis followed by 3% agarose gel electrophoresis. Applicable statistical methods were used to assess relationships between vitiligo cases and controls. MAIN OUTCOM MEASURE: Effect of genotype distribution among four single nucleotide polymorphisms. SAMPLE SIZE: 152 vitiligo (median [IQR] 23 [19] years) patients and 159 healthy controls (45 [28.5] years). RESULTS: We found an association of vitiligo with ApaI and BsmI polymorphisms (P<.05). However, a decreased risk was noted in vitiligo patients with FokI and TaqI polymorphisms and in the diplotype and haplotype analysis within males and females. A positive association with vitiligo was observed in ACAC and AC (adjusted by gender) haplotypes (P<.05). The strongest linkage disequilibrium was observed between rs79785232 (ApaI) and rs731236 (TaqI) polymorphisms (r2=.83), followed by rs2228570 (FokI) and rs1544410 (BsmI) polymorphisms (r2=.53). CONCLUSIONS: Our results confirm an association of vitiligo with ApaI and BsmI polymorphisms and fail to show an association in TaqI and FokI polymorphism with vitiligo. Additional studies need to be carried out in different Arab populations to determine whether the polymorphisms are present. LIMITATIONS: Controls not age matched, small sample size, lack of biochemical parameters. CONFLICT OF INTEREST: None.
背景:白癜风是一种常见的皮肤和头发疾病,由系统性色素脱失症引起,由于发病于成年早期,影响1%或更少的人群。荟萃分析证明了白癜风与维生素D受体(VDR)基因之间的联系。目的:研究沙特人群中VDR基因ApaI、BsmI、FokI和TaqI基因变异与白癜风的关系。设计:病例对照。单位:单一的三级护理中心。患者和方法:该病例对照研究于2015年1月至2015年12月在沙特白癜风患者和健康对照中进行。VDR基因变异或多态性(ApaI、BsmI、FokI和TaqI)通过聚合酶链式反应限制性片段长度分析和3%琼脂糖凝胶电泳进行基因分型。使用适用的统计方法来评估白癜风病例和对照组之间的关系。主要输出测量:四种单核苷酸多态性中基因型分布的影响。样本量:152名白癜风患者(中位[IQR]23[19]岁)和159名健康对照(45[28.5]岁)。结果:我们发现白癜风与ApaI和BsmI多态性有关(P<0.05)。然而,在FokI和TaqI多态性的白癜风患者中,以及在男性和女性的双型和单倍型分析中,风险降低。ACAC和AC(按性别调整)单倍型与白癜风呈正相关(P<0.05)。rs79785232(ApaI)和rs731236(TaqI)多态性之间存在最强的连锁不平衡(r2=.83),其次是rs2228570(FokI)和rs1544410(BsmI)多态性(r2=.53)。结论:我们的结果证实了白癜风与ApaI和BsmI多态性的相关性,而没有显示TaqI和FokI多态性与白癜风的相关性。需要在不同的阿拉伯人群中进行额外的研究,以确定是否存在多态性。局限性:对照组年龄不匹配,样本量小,缺乏生化参数。利益冲突:无。
{"title":"Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: a case-control study","authors":"G. B. Saif, I. Khan","doi":"10.5144/0256-4947.2022.96","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.96","url":null,"abstract":"BACKGROUND: Vitiligo is a common cutaneous disorder of the skin and hair caused by a systemic depigmentation disorder that affects 1% of the population or less due to its onset in early adulthood. Meta-analyses have documented a linkage between vitiligo and the vitamin D receptor (VDR) gene. OBJECTIVE: Investigate the relationship between the ApaI, BsmI, FokI and TaqI genetic variants in the VDR gene with vitiligo in a Saudi population. DESIGN: Case-control. SETTING: Single tertiary care center. PATIENT AND METHODS: The case-control study was carried out between January 2015-December 2015 in Saudi vitiligo patients and healthy controls. VDR genetic variants or polymorphisms (ApaI, BsmI, FokI and TaqI) were genotyped by polymerase chain reaction-restriction fragment length analysis followed by 3% agarose gel electrophoresis. Applicable statistical methods were used to assess relationships between vitiligo cases and controls. MAIN OUTCOM MEASURE: Effect of genotype distribution among four single nucleotide polymorphisms. SAMPLE SIZE: 152 vitiligo (median [IQR] 23 [19] years) patients and 159 healthy controls (45 [28.5] years). RESULTS: We found an association of vitiligo with ApaI and BsmI polymorphisms (P<.05). However, a decreased risk was noted in vitiligo patients with FokI and TaqI polymorphisms and in the diplotype and haplotype analysis within males and females. A positive association with vitiligo was observed in ACAC and AC (adjusted by gender) haplotypes (P<.05). The strongest linkage disequilibrium was observed between rs79785232 (ApaI) and rs731236 (TaqI) polymorphisms (r2=.83), followed by rs2228570 (FokI) and rs1544410 (BsmI) polymorphisms (r2=.53). CONCLUSIONS: Our results confirm an association of vitiligo with ApaI and BsmI polymorphisms and fail to show an association in TaqI and FokI polymorphism with vitiligo. Additional studies need to be carried out in different Arab populations to determine whether the polymorphisms are present. LIMITATIONS: Controls not age matched, small sample size, lack of biochemical parameters. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"96 - 106"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42516138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Neurological outcomes in adult drowning patients in China 中国成年溺水患者的神经系统结果
IF 1.6 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 DOI: 10.5144/0256-4947.2022.127
P. Zhou, Huaqing Xu, Bingccan Li, Chenbing Yang, Zhiliang Zhou, Jincun Shi, Zhangping Li
BACKGROUND: Drowning is the third leading cause of unintentional death worldwide. The epidemiological characteristics of adult drownings are rarely reported. OBJECTIVE: Investigate factors associated with neurological prognosis in adult drowning inpatients. DESIGN: Multicenter medical record review. SETTING: Tertiary health care institutions. PATIENTS AND METHODS: We collected demographic and clinical data on patients who drowned but survived between September 2006 and January 2020. Neurological prognosis was compared in patients with and without cardiac arrest. MAIN OUTCOME MEASURES: Neurological outcomes. SAMPLE SIZE AND CHARACTERISTICS: 142 patients with mean age of 50.6 (19.8) years, male/female ratio of 1.54:1. RESULT: Forty-five patients (31.7%) received CPR, 90 patients (63.4%) experienced unconsciousness, and 59 patients (41.5%) received endotracheal intubation and mechanical ventilation. Multivariate logistic regression analysis showed that the initial blood lactic acid level (OR: 7.67, 95%CI: 1.23-47.82, P=.029) was associated with a poor neurological prognosis in patients without cardiac arrest. The incidence of ICU admission (OR: 16.604, 95%CI: 1.15-239.49, P=.039) was associated with a poor neurologic prognosis in patients with cardiac arrest. CONCLUSIONS: For the drowning patients with cardiac arrest, ICU admission was associated with neurological function prognosis in these patients. Among the patients without cardiac arrest, the initial lactate value was associated with neurological function prognosis of these patients. LIMITATIONS: Retrospective. CONFLICT OF INTEREST: None.
背景:溺水是世界范围内非故意死亡的第三大原因。成人溺水的流行病学特征很少报道。目的:探讨影响成人溺水患者神经系统预后的因素。设计:多中心病历审查。单位:三级医疗机构。患者和方法:我们收集了2006年9月至2020年1月期间溺水但幸存的患者的人口统计学和临床数据。比较有和无心脏骤停患者的神经系统预后。主要观察指标:神经系统结果。样本量和特征:142名患者,平均年龄50.6(19.8)岁,男女比例为1.54:1。结果:45例(31.7%)患者接受心肺复苏术,90例(63.4%)患者出现意识障碍,59例(41.5%)患者接受气管插管和机械通气。多变量逻辑回归分析显示,在没有心脏骤停的患者中,初始血乳酸水平(OR:7.67,95%CI:1.23-7.82,P=0.029)与不良的神经预后相关。入住ICU的发生率(OR:16.604,95%CI:1.15-239.49,P=.039)与心脏骤停患者的神经预后不良有关。结论:对于心脏骤停的溺水患者,入住ICU与这些患者的神经功能预后有关。在没有心脏骤停的患者中,初始乳酸值与这些患者的神经功能预后有关。限制:回顾性。利益冲突:无。
{"title":"Neurological outcomes in adult drowning patients in China","authors":"P. Zhou, Huaqing Xu, Bingccan Li, Chenbing Yang, Zhiliang Zhou, Jincun Shi, Zhangping Li","doi":"10.5144/0256-4947.2022.127","DOIUrl":"https://doi.org/10.5144/0256-4947.2022.127","url":null,"abstract":"BACKGROUND: Drowning is the third leading cause of unintentional death worldwide. The epidemiological characteristics of adult drownings are rarely reported. OBJECTIVE: Investigate factors associated with neurological prognosis in adult drowning inpatients. DESIGN: Multicenter medical record review. SETTING: Tertiary health care institutions. PATIENTS AND METHODS: We collected demographic and clinical data on patients who drowned but survived between September 2006 and January 2020. Neurological prognosis was compared in patients with and without cardiac arrest. MAIN OUTCOME MEASURES: Neurological outcomes. SAMPLE SIZE AND CHARACTERISTICS: 142 patients with mean age of 50.6 (19.8) years, male/female ratio of 1.54:1. RESULT: Forty-five patients (31.7%) received CPR, 90 patients (63.4%) experienced unconsciousness, and 59 patients (41.5%) received endotracheal intubation and mechanical ventilation. Multivariate logistic regression analysis showed that the initial blood lactic acid level (OR: 7.67, 95%CI: 1.23-47.82, P=.029) was associated with a poor neurological prognosis in patients without cardiac arrest. The incidence of ICU admission (OR: 16.604, 95%CI: 1.15-239.49, P=.039) was associated with a poor neurologic prognosis in patients with cardiac arrest. CONCLUSIONS: For the drowning patients with cardiac arrest, ICU admission was associated with neurological function prognosis in these patients. Among the patients without cardiac arrest, the initial lactate value was associated with neurological function prognosis of these patients. LIMITATIONS: Retrospective. CONFLICT OF INTEREST: None.","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"127 - 138"},"PeriodicalIF":1.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42673784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients. 甲状腺良性结节与正常甲状腺患者25-羟基维生素D水平的关系
IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2022-03-01 Epub Date: 2022-04-07 DOI: 10.5144/0256-4947.2022.83
Hacı Bolat, Aliriza Erdoğan

Background: The presence of nodules in the thyroid gland is common in iodine-deficient areas of the world. Recently, vitamin D levels were found to be lower than normal and sometimes deficient in malignant nodules of the thyroid.

Objective: Evaluate the relationship between the serum vitamin D levels and benign thyroid nodules in euthyroid patients.

Design: Cross-sectional.

Setting: Tertiary care center in Turkey.

Patients and methods: Patients referred to the general surgery outpatient clinic and diagnosed with thyroid nodules were the study group. The control group consisted of healthy individuals without thyroid nodules. Age, BMI, thyroid ultrasonography, serum 25-hydroxyvitamin D, free T3, free T4, thyroid stimulating hormone, calcium, magnesium, phosphorous, total protein, albumin, glucose, creatinine levels and glomerular filtration rate (GFR) were compared between groups.

Main outcome measure: Serum 25-hydroxy-vitamin D levels and size of the thyroid nodules.

Sample size and characteristics: Of 849 individuals, 453 were patients with thyroid nodules and 396 were healthy individuals.

Results: The mean serum vitamin D levels of patients with thyroid nodules were significantly lower than controls (P<.001). Serum vitamin D levels along with serum total protein levels and eGFR were independent variables associated with the presence of a thyroid nodule (P<.001, p=.005 and P=.017, respectively).

Conclusion: These findings suggest vitamin D deficiency might be one of the pathophysiologic factors in development of thyroid nodules.

Limitation: Single-center and possible information bias.

Conflicts of interest: None.

背景:甲状腺结节的存在是常见的在世界缺碘地区。最近,在甲状腺恶性结节中发现维生素D水平低于正常水平,有时缺乏。目的:探讨甲状腺功能正常患者血清维生素D水平与良性甲状腺结节的关系。设计:横断面。地点:土耳其三级医疗中心。患者和方法:在普通外科门诊就诊并诊断为甲状腺结节的患者为研究组。对照组为无甲状腺结节的健康人。比较两组患者年龄、BMI、甲状腺超声、血清25-羟基维生素D、游离T3、游离T4、促甲状腺激素、钙、镁、磷、总蛋白、白蛋白、葡萄糖、肌酐水平及肾小球滤过率(GFR)。主要观察指标:血清25-羟基维生素D水平和甲状腺结节大小。样本量和特征:849人中,453人为甲状腺结节患者,396人为健康个体。结果:甲状腺结节患者的平均血清维生素D水平显著低于对照组(P< 0.001)。血清维生素D水平、血清总蛋白水平和eGFR是与甲状腺结节存在相关的独立变量(P< 0.05)。001, p =。005, P=。017年,分别)。结论:维生素D缺乏可能是甲状腺结节发生的病理生理因素之一。局限性:单中心和可能的信息偏倚。利益冲突:无。
{"title":"Benign nodules of the thyroid gland and 25-hydroxy-vitamin D levels in euthyroid patients.","authors":"Hacı Bolat, Aliriza Erdoğan","doi":"10.5144/0256-4947.2022.83","DOIUrl":"10.5144/0256-4947.2022.83","url":null,"abstract":"<p><strong>Background: </strong>The presence of nodules in the thyroid gland is common in iodine-deficient areas of the world. Recently, vitamin D levels were found to be lower than normal and sometimes deficient in malignant nodules of the thyroid.</p><p><strong>Objective: </strong>Evaluate the relationship between the serum vitamin D levels and benign thyroid nodules in euthyroid patients.</p><p><strong>Design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>Tertiary care center in Turkey.</p><p><strong>Patients and methods: </strong>Patients referred to the general surgery outpatient clinic and diagnosed with thyroid nodules were the study group. The control group consisted of healthy individuals without thyroid nodules. Age, BMI, thyroid ultrasonography, serum 25-hydroxyvitamin D, free T3, free T4, thyroid stimulating hormone, calcium, magnesium, phosphorous, total protein, albumin, glucose, creatinine levels and glomerular filtration rate (GFR) were compared between groups.</p><p><strong>Main outcome measure: </strong>Serum 25-hydroxy-vitamin D levels and size of the thyroid nodules.</p><p><strong>Sample size and characteristics: </strong>Of 849 individuals, 453 were patients with thyroid nodules and 396 were healthy individuals.</p><p><strong>Results: </strong>The mean serum vitamin D levels of patients with thyroid nodules were significantly lower than controls (<i>P</i><.001). Serum vitamin D levels along with serum total protein levels and eGFR were independent variables associated with the presence of a thyroid nodule (<i>P</i><.001, p=.005 and <i>P</i>=.017, respectively).</p><p><strong>Conclusion: </strong>These findings suggest vitamin D deficiency might be one of the pathophysiologic factors in development of thyroid nodules.</p><p><strong>Limitation: </strong>Single-center and possible information bias.</p><p><strong>Conflicts of interest: </strong>None.</p>","PeriodicalId":8016,"journal":{"name":"Annals of Saudi Medicine","volume":"42 1","pages":"83-88"},"PeriodicalIF":1.5,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44433013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Saudi Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1